Firms

Catalio Capital Management
New York, New York · Baltimore, Maryland · Bethesda · New York City · United Kingdom
Signal profile (Catalio Capital Management) Catalio Capital Management
- Founded
- —
- Type
- Venture capital
Team
![]() Matthew Hobson Catalio Capital Management, Principal | $1M$100K – $5M | Baltimore, Maryland |
![]() Tom V. Brooks Catalio Capital Management, General Partner | $1M$100K – $5M | Baltimore, Maryland |
![]() R. Jacob Vogelstein Catalio Capital Management, Managing Partner | $1M$100K – $5M | Bethesda |
![]() George C. Petrocheilos Catalio Capital Management, Managing Partner | $1M$100K – $5M | New York, New York |
![]() Nicholas von Guionneau Catalio Capital Management, Investor (Signal team listing) | $1M$100K – $5M | United Kingdom |
![]() Kenan Turnacioglu Catalio Capital Management, General Partner | $25K$5K – $50K | New York City |
Co-investing
ARCH Venture Partners
Pheast Therapeutics$76M · 2022-04-26
Neumora Therapeutics, Inc.$— · 2021-10-07
Volastra$44M · Unknown date
Syndeio Biosciences$90M · Unknown date
Volastra Therapeutics$60M · Unknown date
Volastra Therapeutics$44M · Unknown date
General Catalyst
Somethings$19M · 2026-02-10
Beacon Biosignals$86M · 2025-11
Elektrofi$112M · 2024-10-31
Elektrofi, Inc.$112M · 2024-10-31
Georgiamune$75M · 2023
Odyssey Therapeutics$168M · 2022-10-13
Alexandria Venture Investments
Georgiamune$75M · 2023
Odyssey Therapeutics$168M · 2022-10-13
Pheast Therapeutics$76M · 2022-04-26
Neumora Therapeutics, Inc.$— · 2021-10-07
Bain CapitalKailera$600M · 2025-10-14
Freenome$300M · 2021-12-07
AdvanCell$315M · Unknown date
Imperative Care$260M · Unknown date
Polaris Partners
- Satellite Bio$110M · Unknown date
Volastra$44M · Unknown date
Volastra Therapeutics$60M · Unknown date
Volastra Therapeutics$44M · Unknown date
Bluestem Capital Company
ORASIS Pharmaceuticals$78M · 2024-10-08
Orasis$78M · 2024-10-08ORASIS Pharmaceuticals$30M · 2020
Logos Capital
Beacon Biosignals$86M · 2025-11
Elektrofi$112M · 2024-10-31
Elektrofi, Inc.$112M · 2024-10-31
Pura Vida Investments
Freenome$300M · 2021-12-07
AtaiBeckley$— · Unknown date
Imperative Care$260M · Unknown date
S32
Beacon Biosignals$86M · 2025-11
Freenome$300M · 2021-12-07
Character Biosciences$93M · Unknown date
SequoiaORASIS Pharmaceuticals$78M · 2024-10-08
Orasis$78M · 2024-10-08ORASIS Pharmaceuticals$30M · 2020
T. Rowe Price
Kailera$600M · 2025-10-14
Odyssey Therapeutics$168M · 2022-10-13
AdvanCell$315M · Unknown date
Visionary Ventures
ORASIS Pharmaceuticals$78M · 2024-10-08
Orasis$78M · 2024-10-08ORASIS Pharmaceuticals$30M · 2020
Alpha Wave Global
AtaiBeckley$— · Unknown date
AdvanCell$315M · Unknown date
Casdin Capital
Beacon Biosignals$86M · 2025-11
Character Biosciences$93M · Unknown date
Cormorant Asset Management
Volastra Therapeutics$60M · Unknown date
Volastra Therapeutics$44M · Unknown date
Deep Track Capital
Elektrofi$112M · 2024-10-31
Elektrofi, Inc.$112M · 2024-10-31
Eli Lilly and Company
Syndeio Biosciences$90M · Unknown date
Volastra Therapeutics$60M · Unknown date
Maverick Ventures
ORASIS Pharmaceuticals$78M · 2024-10-08
Orasis$78M · 2024-10-08
Polaris Innovation Fund
Neumora Therapeutics, Inc.$— · 2021-10-07- Satellite Bio$110M · Unknown date
Sanofi Ventures
Character Biosciences$93M · Unknown date
AdvanCell$315M · Unknown date
SR One
Elektrofi$112M · 2024-10-31
Elektrofi, Inc.$112M · 2024-10-31
AbbVie
Syndeio Biosciences$90M · Unknown date
Adage Capital Management
Kailera$600M · 2025-10-14
Alumni Ventures
Beacon Biosignals$86M · 2025-11
aMoon
Character Biosciences$93M · Unknown date
Anthony Philippakis
Beacon Biosignals$86M · 2025-11
Arbor Ventures
Orasis$78M · 2024-10-08
Ascension Ventures
Imperative Care$260M · Unknown date
Atlas Venture
Kailera$600M · 2025-10-14
Braidwell LP
Elektrofi$112M · 2024-10-31
BVF Partners L.P.
Elektrofi, Inc.$112M · 2024-10-31
Canada Pension Plan Investment Board
Kailera$600M · 2025-10-14
Colt Ventures
Odyssey Therapeutics$168M · 2022-10-13
Cowen Healthcare Investments
Freenome$300M · 2021-12-07
D1 Capital Partners
Imperative Care$260M · Unknown date
Delos Capital
Imperative Care$260M · Unknown date
Eventide Asset Management
AdvanCell$315M · Unknown date
F-Prime Capital
Neumora Therapeutics, Inc.$— · 2021-10-07
Founders Fund
AtaiBeckley$— · Unknown date
Galaxy Ventures
AtaiBeckley$— · Unknown date
GV
Beacon Biosignals$86M · 2025-11
Hemant Taneja
Beacon Biosignals$86M · 2025-11
Human Capital
Medra$52M · 2025-12-11
Iaso Ventures
Beacon Biosignals$86M · 2025-11
Indicator Ventures
Beacon Biosignals$86M · 2025-11
Innovation Endeavors
Character Biosciences$93M · Unknown date
Innoviva
Beacon Biosignals$86M · 2025-11
Lightspeed- Satellite Bio$110M · Unknown date
Lux Capital
Medra$52M · 2025-12-11
Menlo Ventures
Medra$52M · 2025-12-11
Mubadala Ventures
Georgiamune$75M · 2023
Nexus NeuroTech Ventures
Beacon Biosignals$86M · 2025-11
Palo Santo
Syndeio Biosciences$90M · Unknown date
re.Mind Capital
Neumora Therapeutics, Inc.$— · 2021-10-07
Redpoint Ventures
Odyssey Therapeutics$168M · 2022-10-13
Roche Venture Fund
Freenome$300M · 2021-12-07
Section 32
Freenome$300M · 2021-12-07
Seven Seven Six
Medra$52M · 2025-12-11
Synetro Group
Beacon Biosignals$86M · 2025-11
Takeda
Beacon Biosignals$86M · 2025-11
Tenmile
Syndeio Biosciences$90M · Unknown date
Thiel Capital
AtaiBeckley$— · Unknown date
Tusk Venture Partners
Somethings$19M · 2026-02-10
Vasudev Bailey
Freenome$300M · 2021-12-07






